BioWorld Articlehttps://www.bioworld.com/content/telesta-therapeutics-mcna-gets-thumbs-down-joint-fda-adcom-nmibc-0 This article is old but shows some of the confusion. Management needs to clear things up. Maybe they can resubmit differently or someone with better resources can just buy them out and take over. Glta